Utilization of Natural Products as a Source of Novel Antibiotics: A Literature Review
DOI:
https://doi.org/10.51574/hayyan.v2i2.3128Keywords:
natural products, antibiotic resistance, antibacterial compounds, novel antibiotic, drug discoveryAbstract
Antibiotic resistance is a growing global health concern that threatens the effectiveness of current treatments against bacterial infections. Natural products have long served as essential reservoirs for the discovery of bioactive compounds, including antibiotics, owing to their structural diversity and ecological functions. This literature review highlights recent advances (2016–2025) in the identification and development of novel antibacterial compounds derived from natural sources such as medicinal plants, soil actinomycetes, marine organisms, endophytes, and extremophiles. It also discusses the molecular mechanisms underlying their antibacterial actions and addresses modern approaches in natural product-based drug discovery, including genome mining, metabolomics, artificial intelligence, and synthetic biology. Despite various challenges, such as the rediscovery of known molecules and low yields, innovative strategies continue to drive the development of promising antibiotic candidates. This review emphasizes the untapped potential of natural resources and advanced technologies in tackling the global antimicrobial resistance crisis.
References
Abdallah, E. M., et al. (2023). Back to nature: Medicinal plants as promising sources for antibacterial drugs in the post-antibiotic era. Plants, 12(17), 3077.
Alves Júnior, E. F., et al. (2024). Natural antibiotics against antimicrobial resistance: Sources and potential applications. World Journal of Microbiology and Biotechnology, 40(7), 123–135.
Baranova, A. A., Singh, N., Hesse, J., & Sieber, S. A. (2023). Modern trends in natural antibiotic discovery. Life, 13(5), 1073. https://doi.org/10.3390/life13051073
Barka, E. A., Vatsa, P., Sanchez, L., Gavaut-Vaillant, N., Jacquard, C., Klenk, H. P., ... & Clément, C. (2016). Taxonomy, physiology, and natural products of Actinobacteria. Microbiology and Molecular Biology Reviews, 80(1), 1–43.
Beemelmanns, C., Keller, A., & Müller, R. (2024). Mining the microbiota for antibiotics. Nature Microbiology, 9, 13–14.
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H., & Prinsep, M. R. (2018). Marine natural products. Natural Product Reports, 35(1), 8–53.
Covington, B. C., Xu, F., & Seyedsayamdost, M. R. (2021). A natural product chemist’s guide to unlocking silent biosynthetic gene clusters. Annual Review of Biochemistry, 90, 763–788
Fergusson, C. H., Kim, Y. M., Wu, L., et al. (2024). Discovery of a lagriamide polyketide by integrated genome mining, isotopic labeling, and untargeted metabolomics. Chemical Science.
Ganbarov, K., et al. (2025). Enhancing antibiotic efficacy with natural compounds: Synergistic activity against pathogenic bacteria. Frontiers in Microbiology, 11, 566325.
Górniak, I., Bartoszewski, R., & Króliczewski, J. (2019). Comprehensive review of antimicrobial activities of plant flavonoids. Phytochemistry Reviews, 18(1), 241–272.
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2019a). The re-emergence of natural products for drug discovery in the genomics era. Nature Reviews Drug Discovery, 18(2), 95–111.
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2019b). Natural product drug discovery: Past successes and future challenges. Natural Product Reports, 36(7), 857–877.
Hassan, M. I., Farag, M. A., & Elmaidomy, A. H. (2022). Antimicrobial potentials of natural products against multidrug resistance pathogens: A comprehensive review. RSC Advances, 12(45), 29078–29102.
Imai, Y., et al. (2019). A new antibiotic selectively kills Gram-negative pathogens. Nature, 576(7787), 459–464.
Imran, M., Ghorai, P., & Banerjee, U. C. (2021). Marine microorganisms as a source of antimicrobial agents: Current status and future perspectives. World Journal of Microbiology and Biotechnology, 37, 99.
Jasim, B., Anisha, C., John, J., & Mathew, J. (2016). Isolation and characterization of plant-associated endophytic Streptomyces sp. producing antibacterial metabolites. 3 Biotech, 6(2), 1–7.
Kumar, R., Tiwari, A. K., Gaurav, A., & Sharma, R. (2020). Antimicrobial peptides from insects: A novel source for therapeutics. Journal of Applied Microbiology, 129(4), 911–926.
Kumar, S., & Singh, R. (2020). Pharmacokinetics and toxicity considerations in natural product drug development. Phytomedicine, 70, 153210.
Kusari, S., Spiteller, M., & Kayser, O. (2018). Endophytes as a source of bioactive natural products: Current status and future perspectives. Natural Product Reports, 35(4), 503–535.
Li, J., et al. (2018). Challenges in natural product-based antibiotic discovery. Frontiers in Microbiology, 9, 2865.
Ling, L. L., et al. (2015). A new antibiotic kills pathogens without detectable resistance. Nature, 517(7535), 455–459.
Mishra, R., et al. (2020). Natural anti-biofilm agents: Strategies to control biofilm-forming pathogens. Frontiers in Microbiology, 11, 566325.
Newman, D. J., & Cragg, G. M. (2020). Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019: Review and update. Journal of Natural Products, 83(3), 770–803.
Nothias, L. F., et al. (2020). Feature-based molecular networking in the GNPS analysis environment. Nature Methods, 17(9), 905–908.
Ongena, M., & Jacques, P. (2020). Bacillus lipopeptides: Versatile weapons for plant disease biocontrol. Trends in Microbiology, 28(6), 493–507.
Park, S. Y., Bae, J. Y., & Lee, C. W. (2021). Antibacterial and anti-biofilm activity of fucoxanthin against clinical isolates of Pseudomonas aeruginosa. Marine Drugs, 19(4), 219.
Schuh, M. G., Hesse, J., & Sieber, S. A. (2025). AI-guided antibiotic discovery pipeline from target selection to compound identification. arXiv preprint, arXiv:2504.11091.
Singh, P., & Dubey, A. K. (2020). Endophyte-mediated synthesis of bioactive compounds: A promising approach for novel antibiotic discovery. Microbial Pathogenesis, 147, 104320.
Singh, P., et al. (2021). Isolation difficulties limit antibiotic development from microbial sources. Journal of Antibiotic Research, 74(4), 215–224.
Subramani, R., & Sipkema, D. (2019). Marine rare actinomycetes: A promising source of structurally diverse and unique novel natural products. Marine Drugs, 17(5), 249.
Szymczak, P., & Szczurek, E. (2023). Artificial intelligence-driven antimicrobial peptide discovery. arXiv preprint, arXiv:2308.10921
Thakur, M., & Gupta, V. (2023). Economic challenges in antibiotic R&D: A review. Drug Development Research, 84(5), 1027–1036.
Tiwari, K., & Gupta, R. K. (2017). Rare actinomycetes: A potential storehouse for novel antibiotics. Critical Reviews in Biotechnology, 37(7), 855–869.
Wang, J. Y., & Poinar, H. N. Jr. (2023). Antimicrobial peptides for combating drug-resistant infections. Current Opinion in Pharmacology, 70, 102345.
Wang, J. Y., & Poinar, H. N. Jr. (2024). Progress in exploring new environments for novel antibiotics. Nature Reviews Chemistry, 8(3), 123–135.
World Health Organization. (2020). Global action plan on antimicrobial resistance. WHO Press.
Zhang, Y., Wang, Y., Xie, Y., et al. (2023). Synthetic biology approaches for natural product biosynthesis. Current Opinion in Biotechnology, 79, 102884.
Zhao, X., et al. (2022). Genome mining approaches for novel antibiotic discovery. Microbial Biotechnology, 15(2), 345–360.
